INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...

The microbiome of infants is shaped by social relationships from an early age and not only by family sources, finds a recent ...

Three undergraduates, one medical student and one doctoral student were named among this year’s classes of Marshall, ...

In a world first, a research team led by the University of Oxford’s Department of Engineering Science has shown it is ...

Based on his performance in critical metrics, this wide receiver prospect has the best odds of success in the 2026 draft ...

A hand stencil left on an Indonesian cave wall at least 67,800 years ago may reveal how and when ancient humans reached a ...

PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven ...

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year, but two of them far outstrip the others in sales ...

CHS and CoSA grad Michael Silberblatt wins Best Supporting Performance at the AFIN International Film Festival in Australia.

Companies are integrating artificial Intelligence into all aspects of work and are now doing the same to life.

Scientists have collaborated to develop a new class of highly precise filtration membranes. The research, published in the ...

Flagler Palm Coast Principal Bobby Bossardet grew up as a wrestler, an individual sport if ever there was one. He won an ...